tradingkey.logo

Caris Life Sciences Inc

CAI

33.660USD

+0.540+1.63%
Close 09/16, 16:00ETQuotes delayed by 15 min
9.46BMarket Cap
LossP/E TTM
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2025Q2
FY2025Q1
Operating cash flows (indirect method)
Cash flow from continuing operating activities
--7.29M
---31.34M
Net income from continuing operations
---71.79M
---102.58M
Operating gains losses
--6.41M
--7.04M
Other non-cash items
--27.94M
--3.85M
Change in working capital
---1.44M
--13.32M
-Change in receivables
--29.13M
--7.91M
-Change in inventory
---4.68M
--2.06M
-Change in prepaid expenses
---4.74M
--2.47M
-Change in other current assets
--298.00K
--36.00K
Cash from non-recurring investing activities
Cash from operating activities
--7.29M
---31.34M
Investing cash flow
Net cash from continuing investing activities
--1.39M
--2.69M
Capital expenditures
--1.39M
--2.69M
Net cash flow from disposal of fixed assets
--1.39M
--2.69M
Net cash flow from investment products
--0.00
--0.00
Cash from non-current investing activities
Net cash flow from investing activities
---1.39M
---2.69M
Financing cash flow
Cash flow from continuous financing activities
--681.40M
--1.28M
Net cash flow from debt Issuance/repayment
--23.84M
---22.00K
Net cash flow from common stock issuance/repurchase
--528.46M
---22.00K
Net cash flow from preferred stock issuance/repurchase
--121.24M
----
Proceeds from stock option exercised by employees
--1.19M
--1.43M
Proceeds from issuance of warrants
--10.27M
----
Net cash flow from other financing activities
---3.60M
---105.00K
Net cash from non-recurrent financing activities
Net cash from financing activities
--681.40M
--1.28M
Net cash flow
Beginning cash balance
--35.29M
--68.03M
Current period cash flow changes
--687.40M
---32.74M
Effect of exchange rate changes
--93.00K
--4.00K
Ending cash balance
--722.69M
--35.29M
Free cash flow
--5.90M
---34.03M
Currency unit
USD
USD
Audit opinions
--
--
KeyAI